Scorpion Venom Could Serve as an Alternative to Morphine
|
By HospiMedica International staff writers Posted on 10 Mar 2010 |

Image: The Israeli desert scorpion Leiurus quinquestriatus (photo courtesy Wikipedia).
Scorpion venom, a notorious poison, might be used as an alternative to dangerous and addictive painkillers such as morphine, according to a new study.
Researchers at Tel Aviv University (Israel), using an approach called rational design, are trying to develop a novel painkiller based on natural compounds found in the venom of the Israeli (family Buthidae) yellow scorpion--one of the most potent scorpions in the world--by mimicking the venom's bioactive components. The scorpion venom contains more than 300 peptides, of which only a minor fraction has been explored. Among these are the alpha-neurotoxins, which target voltage-gated sodium channels (NA(V)S) and constitute an important component in the venom of the scorpions.
The NA(V)S toxins are short polypeptides highly conserved in sequence, and three-dimensional (3D) in structure, but they differ greatly in activity and preference for insects and various mammals. Despite extensive studies of the structure-function relationship of these toxins, little is known about their evolution and phylogeny. The researchers used a broad dataset based on published sequences and rigorous cloning to reconstruct a reliable phylogenetic tree of the scorpion alpha-toxins, and estimated the evolutionary forces involved in the diversification of their genes. They thus succeeded in isolating the genetic sequences for important neurotoxins in the scorpion venom, and also developed methods to produce and manipulate the toxins. The study describing the investigation process was published on December 17, 2009, in the early online edition of Molecular Biology and Evolution.
"The mammalian body has nine different sodium channels of which only a certain subtype delivers pain to our brain,” said lead author Professor Michael Gurevitz, Ph.D., of the department of plant sciences. "We are trying to understand how toxins in the venom interact with sodium channels at the molecular level and particularly how some of the toxins differentiate among channel subtypes.”
"This new class of drugs could be useful against serious burns and cuts, as well as in the military and in the aftermath of earthquakes and natural disasters,” added Professor Gurevitz. "Instead of running the risk of addiction, this venom-derived drug, mimicking the small peptide toxin, would do what it needs to do and then pass from the body with no traces or side-effects.”
The Israeli Buthidae yellow scorpion--Leiurus quinquestriatus--also known as the Omdurman scorpion or "deathstalker”--is regarded as a highly dangerous species because its venom is a powerful cocktail of neurotoxins. One component of the venom, the peptide chlorotoxin, has shown potential for treating human brain tumors. There has also been some evidence to show that other components of the venom may aid in the regulation of insulin, and could be used to treat diabetes.
Related Links:
Tel Aviv University
Researchers at Tel Aviv University (Israel), using an approach called rational design, are trying to develop a novel painkiller based on natural compounds found in the venom of the Israeli (family Buthidae) yellow scorpion--one of the most potent scorpions in the world--by mimicking the venom's bioactive components. The scorpion venom contains more than 300 peptides, of which only a minor fraction has been explored. Among these are the alpha-neurotoxins, which target voltage-gated sodium channels (NA(V)S) and constitute an important component in the venom of the scorpions.
The NA(V)S toxins are short polypeptides highly conserved in sequence, and three-dimensional (3D) in structure, but they differ greatly in activity and preference for insects and various mammals. Despite extensive studies of the structure-function relationship of these toxins, little is known about their evolution and phylogeny. The researchers used a broad dataset based on published sequences and rigorous cloning to reconstruct a reliable phylogenetic tree of the scorpion alpha-toxins, and estimated the evolutionary forces involved in the diversification of their genes. They thus succeeded in isolating the genetic sequences for important neurotoxins in the scorpion venom, and also developed methods to produce and manipulate the toxins. The study describing the investigation process was published on December 17, 2009, in the early online edition of Molecular Biology and Evolution.
"The mammalian body has nine different sodium channels of which only a certain subtype delivers pain to our brain,” said lead author Professor Michael Gurevitz, Ph.D., of the department of plant sciences. "We are trying to understand how toxins in the venom interact with sodium channels at the molecular level and particularly how some of the toxins differentiate among channel subtypes.”
"This new class of drugs could be useful against serious burns and cuts, as well as in the military and in the aftermath of earthquakes and natural disasters,” added Professor Gurevitz. "Instead of running the risk of addiction, this venom-derived drug, mimicking the small peptide toxin, would do what it needs to do and then pass from the body with no traces or side-effects.”
The Israeli Buthidae yellow scorpion--Leiurus quinquestriatus--also known as the Omdurman scorpion or "deathstalker”--is regarded as a highly dangerous species because its venom is a powerful cocktail of neurotoxins. One component of the venom, the peptide chlorotoxin, has shown potential for treating human brain tumors. There has also been some evidence to show that other components of the venom may aid in the regulation of insulin, and could be used to treat diabetes.
Related Links:
Tel Aviv University
Latest Critical Care News
- Smartphone Heart Rhythm App Reduces Unnecessary Cardioversion Procedures
- Bedside CSF Monitor Detects Early Infection in Fluid Drains
- Wearable Ultrasound Patch Noninvasively Paces Heart to Stabilize Arrhythmias
- New Practice Guidance Supports Prostatic Artery Embolization for BPH Symptoms
- AI ECG Tool Detects Cardiac Amyloidosis for Early Screening
- Cuffless Wearable Enables Continuous Blood Pressure Monitoring for Hypertension Care
- AI-Guided System Supports Cardiac Ultrasound Training on Cart-Based Systems
- AI ECG Index Tracks Pubertal Maturation in Children and Adolescents
- Noninvasive AI Tool Enables Pressure-Guided Heart Failure Management
- Regenerative Therapies Aim to Support Recovery After Traumatic Brain Injury
- Ring-Type Cuffless Monitor Becomes First Added to Official Hypertension Guidelines
- “Intelligent Tattoo” Method Detects Early Melanoma Signals
- Implantable Wireless Light Device Advances Bladder Cancer Treatment
- Reusable Intermittent Catheters Reduce Antibiotic Use Without Increasing Urinary Tract Infections
- Smart Wristband Technology Detects Cardiac Arrest and Alerts Responders
- FDA-Cleared Home Sleep Test Enables Multi-Night Diagnosis of Sleep Apnea
Channels
Artificial Intelligence
view channel
AI Platform Supports Noninvasive Remote Hemodynamic Monitoring in Heart Failure
Heart failure remains a leading cause of hospitalization in adults over 65, affecting more than 6.7 million people in the U.S. Clinicians often lose visibility into hemodynamic deterioration once patients... Read more
AI Tool Predicts Unplanned Care and Symptom Burden in Cancer Survivors
Unplanned emergency visits and hospitalizations remain common in cancer survivorship, when routine clinical contact often tapers while new symptoms emerge. These events reflect unmet needs and disrupt... Read moreCritical Care
view channel
Smartphone Heart Rhythm App Reduces Unnecessary Cardioversion Procedures
Atrial fibrillation, an irregular and often rapid heart rhythm, is the most common arrhythmia in adults. Elective electrical cardioversion is frequently canceled on the day of treatment when patients revert... Read more
New Practice Guidance Supports Prostatic Artery Embolization for BPH Symptoms
Benign prostatic hyperplasia is a noncancerous enlargement of the prostate that can cause lower urinary tract symptoms and impair daily functioning. These symptoms erode sleep, productivity, and sexual... Read more
Bedside CSF Monitor Detects Early Infection in Fluid Drains
External drainage of cerebrospinal fluid (CSF) after traumatic brain injury, hydrocephalus, or hemorrhage carries a significant risk of infection. These infections can prolong intensive care, cause severe... Read more
Wearable Ultrasound Patch Noninvasively Paces Heart to Stabilize Arrhythmias
Cardiac arrhythmias, including slow and irregular heart rhythms, often require pacemakers that are surgically implanted. While effective, implants carry procedural risks and long-term device maintenance burdens.... Read moreSurgical Techniques
view channel
CE-Marked Ultrasonic Shears Streamline Breast and Thyroid Surgery
Thyroid and breast surgeries are often performed in confined anatomical spaces near critical structures, making precise dissection and controlled thermal management essential. As the global disease burden... Read more
3D Map of Heart Electrical Wiring Aims to Guide Congenital Heart Repair
Tetralogy of Fallot is one of the most common congenital heart problems and often requires surgery in infancy. Many survivors later develop conduction abnormalities because the cardiac electrical system... Read morePatient Care
view channel
AI Avatar Doctor Improves Patient Understanding Before Radiotherapy
Radiation oncology consultations require patients to grasp complex concepts quickly, yet anxiety and information overload often undermine understanding and informed consent. Poor comprehension can also... Read more
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read moreHealth IT
view channel
AI-Native EHR Achieves EU Medical Device Certification
InterSystems (Boston, MA, USA) announced that its IntelliCare electronic health record (EHR) solutions have been certified as Class IIa medical devices under the European Union Medical Device Regulation... Read more
EHR-Integrated Screening Workflow Detects Cognitive Impairment at Admission
Cognitive impairment involves difficulties with thinking, learning, memory, and decision-making, and is more common in older adults. In U.S. hospitals, more than 40% of admitted older adults have dementia,... Read morePoint of Care
view channel
Portable MRI System Accelerates Emergency Brain Imaging and Triage
Emergency departments frequently face delays accessing conventional magnetic resonance imaging (MRI) for patients with suspected neurological emergencies. Such waits can slow triage, prolong boarding,... Read more







